Sei Investments CO Halozyme Therapeutics, Inc. Transaction History

Sei Investments CO

$69 Billion
Q2 2024

A detailed history of Sei Investments CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 324,209 shares of HALO stock, worth $18.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

324,209

Previous 329,123 1.49%

Holding current value

$18.4 Million

Previous $13.4 Million 26.79%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$37.81 - $52.4 $185,798 - $257,493	-4,914 Reduced 1.49%	324,209 $17 Million
Q1 2024 May 07, 2024	SELL	$33.68 - $41.95 $5.11 Million - $6.36 Million	-151,673 Reduced 31.55%	329,123 $13.4 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $1.58 Million - $1.99 Million	-47,304 Reduced 8.96%	480,796 $17.8 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $4.89 Million - $5.91 Million	134,129 Added 34.05%	528,100 $20.2 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $465,827 - $595,976	-15,384 Reduced 3.76%	393,971 $14.2 Million
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $1.37 Million - $2.32 Million	41,578 Added 11.31%	409,355 $15.6 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $2.04 Million - $3.02 Million	-50,869 Reduced 12.15%	367,777 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $987,485 - $1.33 Million	25,629 Added 6.52%	418,646 $16.6 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $640,701 - $828,538	-17,154 Reduced 4.18%	393,017 $17.3 Million
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $1.07 Million - $1.37 Million	-33,482 Reduced 7.55%	410,171 $16.4 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $2.21 Million - $2.83 Million	69,515 Added 18.58%	443,653 $17.9 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $548,736 - $662,134	-14,264 Reduced 3.67%	374,138 $15.2 Million
Q2 2021 Aug 06, 2021	SELL	$38.84 - $51.31 $765,497 - $1.01 Million	-19,709 Reduced 4.83%	388,402 $17.6 Million
Q1 2021 May 12, 2021	BUY	$39.51 - $51.45 $3.96 Million - $5.16 Million	100,271 Added 32.57%	408,111 $17 Million
Q4 2020 Feb 08, 2021	SELL	$25.81 - $43.62 $5.82 Million - $9.84 Million	-225,650 Reduced 42.3%	307,840 $13.1 Million
Q3 2020 Dec 04, 2020	SELL	$25.74 - $29.63 $386 - $444	-15 Reduced -0.0%	533,490 $14 Million
Q3 2020 Nov 06, 2020	SELL	$25.74 - $29.63 $371,376 - $427,501	-14,428 Reduced 2.63%	533,505 $14 Million
Q2 2020 Aug 17, 2020	BUY	$16.25 - $26.81 $6.91 Million - $11.4 Million	424,997 Added 345.71%	547,933 $14.7 Million
Q2 2020 Aug 11, 2020	SELL	$16.25 - $26.81 $6.12 Million - $10.1 Million	-376,530 Reduced 75.39%	122,936 $2.43 Million
Q1 2020 May 14, 2020	BUY	$13.9 - $21.83 $5.65 Million - $8.87 Million	406,136 Added 435.16%	499,466 $8.96 Million
Q4 2019 Feb 06, 2020	SELL	$14.93 - $19.53 $798,172 - $1.04 Million	-53,461 Reduced 36.42%	93,330 $1.65 Million
Q3 2019 Nov 12, 2019	BUY	$15.2 - $17.69 $234,703 - $273,151	15,441 Added 11.76%	146,791 $2.28 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $328,113 - $383,948	-22,245 Reduced 14.48%	131,350 $2.26 Million
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $3.11 Million - $3.92 Million	-222,744 Reduced 59.19%	153,595 $2.47 Million
Q3 2018 Nov 08, 2018	BUY	$16.68 - $18.41 $679,126 - $749,563	40,715 Added 12.13%	376,339 $6.84 Million
Q2 2018 Aug 03, 2018	BUY	$16.87 - $20.3 $195,354 - $235,074	11,580 Added 3.57%	335,624 $5.66 Million
Q1 2018 May 11, 2018	BUY	$17.06 - $21.2 $255,678 - $317,724	14,987 Added 4.85%	324,044 $6.35 Million
Q4 2017 Feb 08, 2018	SELL	$16.75 - $20.8 $221,183 - $274,664	-13,205 Reduced 4.1%	309,057 $6.26 Million
Q3 2017 Nov 06, 2017	BUY	$11.76 - $17.4 $3.79 Million - $5.61 Million	322,262	322,262 $5.6 Million

Others Institutions Holding HALO

# of Institutions

488

Shares Held

122M

Call Options Held

208K

Put Options Held

66.3K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.89B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Halozyme Therapeutics, Inc. Transaction History